Fat Kills Cancer: Turning Stem Cells from Fat Tissue into Personalized, Cancer-Targeted Therapeutics
...cer, and support from theSlovakian national cancer genomics program. # # # The mission of the American Association for CancerResearch is to prevent and cure cancer. Founded in 1907, AACR isthe world's oldest and largest professional organization dedicatedto advancing cancer research. The membership incl...GenoLogics Announces Bioinformatics Partnership with Illumina
...ddress geneexpression and genotyping workflows and genomics applications. Thiswill allow for smooth data flow ...ng applications and integrates to awide variety of genomics instruments and software frombest-in-class vendors, such as Illumina. About GenoLogics GenoLogics ...ChemGenex Reports Successful Personalized Dosing of Quinamed at ASCO
...betes and obesity.ChemGenex harnesses the power of genomics for target discovery andvalidation, and in clinical trials to develop more individualizedtherapeutic outcomes. ChemGenex’s lead compound,Ceflatonin®, is currently in phase 2/3 clinical trials forchronic myeloid leukemia (CML) and Quinamed&r...ChemGenex Reports Successful Personalized Dosing of Quinamed at ASCO
...betes and obesity.ChemGenex harnesses the power of genomics for target discovery andvalidation, and in clinical trials to develop more individualizedtherapeutic outcomes. ChemGenex's lead compound, Ceflatonin(R), iscurrently in phase 2/3 clinical trials for chronic myeloid leukemia(CML) and Quinamed(R) is in ......y, anddepression. ChemGenex harnesses the power of genomics for targetdiscovery and validation, and in clinical trials to develop moreindividualized therapeutic outcomes. ChemGenex's lead compound,Ceflatonin(R), is currently in phase 2/3 clinical trials forchronic myeloid leukemia (CML) and Quinamed(R) is in ...... SIGA Technologies is applying viral and bacterial genomics andsophisticated computational modeling in the design and developmentof novel products for the prevention and treatment of seriousinfectious diseases, with an emphasis on products for biologicalwarfare defense. SIGA is a leading company in the discov...... Center, Rotterdam. The combined team performed genomics analyses on tumor samplesfrom multiple myeloma pat... and Development, L.L.C. (J&JPRD) iscontinuing genomics research on VELCADE in additional trials.Studies include a Phase III trial conducted by the Dutch an......lth through preventivemeasures. It uses functional genomics to help in the development ofrisk assessment tests based on the genetic variations in people.The Company also develops and markets nutritional and OTCeutical(R)products. Interleukin has commercialized genetic tests forperiodontal disease risk assessm...